Summary by Moomoo AI
On April 25, 2024, Johnson & Johnson held its 2024 Annual Meeting of Shareholders where several key decisions were made. The company's Board of Directors approved and adopted amended and restated by-laws, effective immediately. These amendments include updates to the procedural requirements for shareholder meetings, director nominations, and voting standards, as well as the adoption of universal proxy rules. Additionally, the company clarified the role of the CEO as also serving as the President unless designated otherwise and updated director and officer indemnification provisions. At the meeting, all 13 Director nominees were elected, the executive compensation was approved on an advisory basis, and PricewaterhouseCoopers LLP was ratified as the independent registered public accounting firm for fiscal year 2024. However, a shareholder proposal regarding gender-based compensation gaps was not approved. The final voting results for each item were disclosed, with the majority of votes in favor of the proposed actions, except for the gender-based compensation proposal.